Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer-Reference-Cited by-同舟云学术

Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer

Published:2014-06-12 Issue:9 Volume:63 Page:939-946
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Chung Moon Jae,Park Jeong Youp,Bang Seungmin,Park Seung Woo,Song Si Young

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-014-1566-3.pdf

Reference29 articles.

1. National Cancer Information Center (2013) Cancer Information Service National Cancer Information Center. http://www.cancer.go.kr/mbs/cancer/subview.jsp?id=cancer_040201000000 . Accessed 12 Aug 2013

2. Geer RJ, Brennan MF (1993) Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 165:68–72

3. Colucci G, Labianca R, Di Costanzo F, Gebbia V, Cartenì G, Massidda B et al (2010) Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study. J Clin Oncol 28:1645–1651

4. Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S et al (2007) Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 25:1960–1966

5. Van Cutsem E, Vervenne WL, Bennouna J, Humblet Y, Gill S, Van Laethem J et al (2009) Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. J Clin Oncol 27:2231–2237

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Current Landscape of Clinical Trials for Immunotherapy in Pancreatic Cancer: A State-of-the-Art Review;Journal of Gastrointestinal Cancer;2024-07-08

2. Current and future immunotherapeutic approaches in pancreatic cancer treatment;Journal of Hematology & Oncology;2024-06-04

3. Limited Clinical Efficacy with Potential Adverse Events in a Pilot Study of Autologous Adoptive Cell Therapy in Canine Oral Malignant Melanoma;Veterinary Sciences;2024-03-28

4. Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation;Biomedical Journal;2023-12

5. Systemic treatment for advanced pancreatic cancer;World Journal of Gastrointestinal Oncology;2023-10-15